The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic reviewStrategies for treatment in Alexander diseaseEvidence-based information on the clinical use of neurofeedback for ADHDCell-based therapy for neural disorders--anticipating challengesGinsenoside rd in experimental stroke: superior neuroprotective efficacy with a wide therapeutic windowA practical guide to the therapy of narcolepsy and hypersomnia syndromesInsomnia pharmacotherapyNeuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's diseaseCellular treatments for spinal cord injury: the time is right for clinical trialsNeurosteroid replacement therapy for catamenial epilepsySpinal cord injury: present and future therapeutic devices and prosthesesBrain mapping as a tool to study neurodegenerationMolecular targets for antiepileptic drug developmentVaccinations for Neuroinfectious Disease: A Global Health PriorityReorganization of Intact Descending Motor Circuits to Replace Lost Connections After InjuryTargeting Lumbar Spinal Neural Circuitry by Epidural Stimulation to Restore Motor Function After Spinal Cord InjuryTreatment of Huntington's disease.Safety and Toxicology of CannabinoidsMitochondrial disease in childhood: nuclear encodedBalancing Proliferation and Connectivity in PTEN-associated Autism Spectrum DisorderTreatment of functional (psychogenic) movement disorders.Surgical treatment of Parkinson's disease: patients, targets, devices, and approaches.Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?Remyelination therapy for multiple sclerosisNovel protective effects of histone deacetylase inhibition on stroke and white matter ischemic injurySmall molecule inhibitors of zinc-dependent histone deacetylasesWhat do we really know about ADHD in college students?Spinal stimulation for movement disorders.Genetic manipulation of cell death and neuroplasticity pathways in traumatic brain injuryClassification of sleep disorders.Role of immunosuppressive therapy for the treatment of multiple sclerosisModels that matter: white matter stroke modelsStrategies for the treatment of restless legs syndromeEpilepsy related to developmental tumors and malformations of cortical developmentA progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") miceDeep brain stimulation for disorders of memory and cognitionNonhuman primate models of stroke for translational neuroprotection research.Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental modelsApplicability of histone deacetylase inhibition for the treatment of spinal muscular atrophyMitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options
P1433
Q22252567-FBA465CE-6659-4B7E-A6CD-563DD48526B5Q24596794-8059AA33-5F66-49A9-96E7-A5F9C29EB64FQ24600947-87B22146-C7A4-4D67-A52C-B7600196E916Q24615515-FF92FEDD-20A5-46F5-A1A2-F792FC703368Q24615554-A7DAD6C3-F851-41C6-A016-A902B390EB26Q24623713-D639CE1F-4162-4E80-9013-17BC9698727BQ24623757-BEC7634E-C0E8-4529-842C-8BD0FFE8DF16Q24630237-B1352766-23F0-48C6-A053-6C5914C4B117Q24630772-9199C850-FDF1-4EA2-B82C-C3B452B78FD9Q24643667-4B98D838-EDD5-49BC-8C11-3C0711E65C9BQ24652597-830C8837-C9F5-4579-A0FB-3D600C3464FAQ24658560-C3490B3F-7DB4-4800-A7DD-151920BDD04DQ24683346-AE116AE8-5A2D-4A94-B290-573CE8AE58BDQ26252588-73250F08-5C59-43AD-9853-21F7ECC2E5E8Q26769019-3DB06FB0-0D99-4FC3-88A8-7295CB0C343EQ26769658-53294A86-6A8E-4B0B-BE23-2951867842AFQ26782004-CC724CA7-D90A-4959-85E6-B2B41FD38EF7Q26798333-82B8412A-50D8-4B70-BA98-B1B9C4EE2599Q26820866-CAF7E6D1-5D2F-44EB-A1BA-50F21A42483CQ26822064-C5DA9585-3EA9-441C-8A8C-42C3411EF30BQ26822388-7E8C53A2-A3C6-4651-AD38-A6DAD33FBD7DQ26823204-D73DB0FB-B8EB-441C-9753-5E78385ABC6BQ26823418-7C2FAD12-010B-4E12-AA6B-A913D8C24D61Q26824246-07880EA4-5EDF-4FE7-87C1-AC1B4175E373Q26824369-D91214AD-6BBB-4FD2-AE5D-9302AE2172C9Q26824515-3FE36858-9650-4A3D-8B13-439978181952Q26825121-F7E45511-D58F-4375-9C89-D4BB841FC201Q26825373-FE7DC258-13D2-4AA3-97F6-6332250D1B7BQ26827071-F424A5C1-2351-4599-BEC5-E126ECC47D74Q26827155-3F5A5D1C-14D4-4122-B0EB-9AFFCE1E8220Q26827467-8DB1EF76-7102-48D0-BA82-937F6EF0DDD8Q26829657-2FAE5D38-4C01-41C6-84AB-A919D6C1A6B8Q26829911-527EDC6B-2225-4531-A791-0517841C5B1DQ26829946-B34174C6-4140-4466-84AC-5A5156DEB1CDQ26859072-4DB9DA2C-02D3-434E-9F1A-EB630E470857Q26859169-8BE08376-CBC2-4311-8AE0-9ED2B53ADFACQ26859430-6899591C-ADA4-4E3D-8A7A-474A3A082AECQ26861471-C94B1EFE-C476-48C3-976D-18EFBF6A4C33Q26864605-0FD83962-01EE-4DF7-BF20-28D427C20EAAQ26865135-A65C5EBC-6B66-4979-AF0A-8F74B746339F
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Springer Science+Business Media
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
英语期刊
@zh
name
Neurotherapeutics
@ast
Neurotherapeutics
@de
Neurotherapeutics
@en
Neurotherapeutics
@es
Neurotherapeutics
@it
Neurotherapeutics
@nl
type
label
Neurotherapeutics
@ast
Neurotherapeutics
@de
Neurotherapeutics
@en
Neurotherapeutics
@es
Neurotherapeutics
@it
Neurotherapeutics
@nl
prefLabel
Neurotherapeutics
@ast
Neurotherapeutics
@de
Neurotherapeutics
@en
Neurotherapeutics
@es
Neurotherapeutics
@it
Neurotherapeutics
@nl
P243
P3181
P1055
P1058
P1144
2006215616
P1156
5100155080
P1160
Neurotherapeutics
P1277
P1476
Neurotherapeutics
@en
P236
P243
P407
P571
2004-01-01T00:00:00Z